(Q48099753)

8 February 2018

title

Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis (English)

1 reference

8 February 2018

0 references

1 reference

F Barkhof

1

1 reference

8 February 2018

M W Tas

2

1 reference

8 February 2018

S T Frequin

3

1 reference

8 February 2018

P Scheltens

4

1 reference

8 February 2018

O R Hommes

5

1 reference

8 February 2018

J J Nauta

6

1 reference

8 February 2018

J Valk

7

1 reference

8 February 2018

publication date

1 July 1994

1 reference

8 February 2018

published in

Neuroradiology

1 reference

8 February 2018

volume

36

1 reference

8 February 2018

issue

5

1 reference

8 February 2018

page(s)

382-387

1 reference

8 February 2018

Long term follow-up of multiple sclerosis by standardized, non-contrast-enhanced magnetic resonance imaging

cites work

1 reference

12 December 2020

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

1 reference

12 December 2020

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis

1 reference

12 December 2020

High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations

1 reference

12 December 2020

Formalin fixed brains are useful for magnetic resonance imaging (MRI) study

1 reference

12 December 2020

The use of immunosuppressive agents in the treatment of multiple sclerosis: a critical review

1 reference

12 December 2020

A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone

1 reference

12 December 2020

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

1 reference

12 December 2020

Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS

1 reference

12 December 2020

Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity

1 reference

12 December 2020

Consensus and controversy in neurologic practice. The case of steroid treatment in multiple sclerosis

1 reference

12 December 2020

Correlation between NMR scan and brain slice data in multiple sclerosis

1 reference

12 December 2020

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

1 reference

12 December 2020

Multiple sclerosis: the impact of MR imaging

1 reference

12 December 2020

Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis

1 reference

12 December 2020

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

12 December 2020

Gadopentetate dimeglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

Methylprednisolone and multiple sclerosis

1 reference

12 December 2020

The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions

1 reference

12 December 2020

Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration

1 reference

12 December 2020

Effect of high-dose intravenous steroid administration on contrast-enhancing computed tomographic scan lesions in multiple sclerosis

1 reference

12 December 2020

Improved correlation of magnetic resonance imaging (MRI) with clinical status in multiple sclerosis (MS) by use of an extensive standardized imaging-protocol.

1 reference

12 December 2020

A commentary on steroid treatment in multiple sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00612124

1 reference

8 February 2018

1 reference

8 February 2018